Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With Placenta Accrete Spectrum Disorders Undergoing Cesarean Hysterectomy
Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: t
View:
• Pregnancy of singleton living fetus
• Previous one or more cesarean sections
• Gestational age: \> 32 weeks
• The following ultrasound markers such as loss of clear retroplacental translucency, myometrial thinning, abnormal lacunae, irregular bladder wall, utero-vesicalhypervascularity.
• Preoperative hemoglobin more than 10 gm/dl
• Cases with PAS that will undergoing CS Hysterectomy
Locations
Other Locations
Egypt
Cairo University
RECRUITING
Cairo
Contact Information
Primary
Abdalla Mousa
Dr_abdallamousa@yahoo.com
+201277664430
Time Frame
Start Date: 2024-07-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 70
Treatments
Experimental: Group (A)
Patients will be given uterotonics
Placebo_comparator: Group (B)
Patients will not be given uterotonics
Related Therapeutic Areas
Sponsors
Leads: Cairo University